<record>
  <isbns></isbns>
  <shortDBName>cmedm</shortDBName>
  <isiType>JOUR</isiType>
  <notes></notes>
  <mid></mid>
  <language>eng</language>
  <source>BMC cancer</source>
  <bookEdition></bookEdition>
  <title>Development of PDAC diagnosis and prognosis evaluation models based on machine learning.</title>
  <pageEnd></pageEnd>
  <pageStart>512</pageStart>
  <peerReviewed>true</peerReviewed>
  <isOpenAccess></isOpenAccess>
  <publicationDate>20250320</publicationDate>
  <pageCount></pageCount>
  <publisherLocations>England</publisherLocations>
  <issue>1</issue>
  <identifiers></identifiers>
  <subjects>Carcinoma, Pancreatic Ductal diagnosis ; Carcinoma, Pancreatic Ductal blood ; Carcinoma, Pancreatic Ductal mortality ; Pancreatic Neoplasms diagnosis ; Pancreatic Neoplasms blood ; Pancreatic Neoplasms mortality ; Machine Learning ; Biomarkers, Tumor blood ; Humans ; Prognosis ; Female ; Male ; Middle Aged ; Aged ; ROC Curve ; Adult ; Proportional Hazards Models ; Diagnosis, Differential ; Support Vector Machine ; Neural Networks, Computer ; Deep Learning</subjects>
  <abstract>Declarations. Ethics approval and consent to participate: This study was approved by the the Fifth Medical Centre of Chinese PLA General Hospital Ethics Committee with the approval number: KY-2024-4-63-1. All patients involved in this study signed informed consent forms, agreeing that their samples could be used for scientific research. This study does not constitute a clinical intervention trial. Clinical Trial Number: Not applicable. The authors confirm that all experiments reported in this study involving humans and/or the use of human tissue samples were conducted in strict accordance with the relevant ethical guidelines and regulations. Consent for publication: The authors confirm that all participants involved in this study have provided written informed consent for the publication of their data, including any potentially identifiable images or personal details, in accordance with the ethical guidelines and policies of our institution and the journal. Competing interests: The authors declare no competing interests.</abstract>
  <pubTypes>Journal Article ; Academic Journal</pubTypes>
  <an>40114140</an>
  <docTypes>Journal Article</docTypes>
  <volume>25</volume>
  <issns>1471-2407 ; Electronic</issns>
  <degreeLevel></degreeLevel>
  <plink>https://research.ebsco.com/linkprocessor/plink?id=f48e6700-b6ad-3d46-9f17-82076af87e82</plink>
  <doids></doids>
  <publisher>BioMed Central</publisher>
  <contributors>Xiao, Yingqi ; Sun, Shixin ; Zheng, Naxin ; Zhao, Jing ; Li, Xiaohan ; Xu, Jianmin ; Li, Haolian ; Du, Chenran ; Zeng, Lijun ; Zhang, Juling ; Yin, Xiuyun ; Huang, Yuan ; Yang, Xuemei ; Yuan, Fang ; Jia, Xingwang ; Li, Boan ; Li, Bo</contributors>
  <coverDate>2025 Mar 20</coverDate>
  <longDBName>MEDLINE</longDBName>
  <doi>10.1186/s12885-025-13929-z</doi>
</record>
